The ANA Screen detects the presence of clinically relevant circulating autoantibodies in serum. Antinuclear antibodies are present in systemic lupus erythematosus, Sjogren’s Syndrome, scleroderma, mixed connective tissue disease, drug induced lupus, and rheumatoid arthritis.